Article Versions Notes

Wang Z, Zou T, Liao C-W, Li X-P, Liu Z-Q, Liu Z-F, Chen J. Association of Erythrocyte-Related Indices with Immune-Related Adverse Events and Survival of Lung Cancer Patients Receiving Immune Checkpoint Inhibitors. Pharmaceuticals. 2025; 18(9):1299. https://doi.org/10.3390/ph18091299

Wang, Zhan, Ting Zou, Chen-Wei Liao, Xiang-Ping Li, Zhao-Qian Liu, Ze-Fu Liu, and Juan Chen. 2025. "Association of Erythrocyte-Related Indices with Immune-Related Adverse Events and Survival of Lung Cancer Patients Receiving Immune Checkpoint Inhibitors" Pharmaceuticals 18, no. 9: 1299. https://doi.org/10.3390/ph18091299

Wang, Z., Zou, T., Liao, C.-W., Li, X.-P., Liu, Z.-Q., Liu, Z.-F., & Chen, J. (2025). Association of Erythrocyte-Related Indices with Immune-Related Adverse Events and Survival of Lung Cancer Patients Receiving Immune Checkpoint Inhibitors. Pharmaceuticals, 18(9), 1299. https://doi.org/10.3390/ph18091299